One year cross-sectional study in adult and neonatal intensive care units reveals the bacterial and antimicrobial resistance genes profiles in patients and hospital surfaces

PLoS One. 2020 Jun 3;15(6):e0234127. doi: 10.1371/journal.pone.0234127. eCollection 2020.

Abstract

Several studies have shown the ubiquitous presence of bacteria in hospital surfaces, staff, and patients. Frequently, these bacteria are related to HAI (healthcare-associated infections) and carry antimicrobial resistance (AMR). These HAI-related bacteria contribute to a major public health issue by increasing patient morbidity and mortality during or after hospital stay. Bacterial high-throughput amplicon gene sequencing along with identification of AMR genes, as well as whole genome sequencing (WGS), are biotechnological tools that allow multiple-sample screening for a diversity of bacteria. In this paper, we used these methods to perform a one-year cross sectional profiling of bacteria and AMR genes in adult and neonatal intensive care units (ICU and NICU) in a Brazilian public, tertiary hospital. Our results showed high abundances of HAI-related bacteria such as S. epidermidis, S. aureus, K. pneumoniae, A. baumannii complex, E. coli, E. faecalis, and P. aeruginosa in patients and hospital surfaces. Most abundant AMR genes detected throughout ICU and NICU were mecA, blaCTX-M-1 group, blaSHV-like, and blaKPC-like. We found that NICU environment and patients were more widely contaminated with pathogenic bacteria than ICU. Patient samples, despite the higher bacterial load, have lower bacterial diversity than environmental samples in both units. Finally, we also identified contamination hotspots in the hospital environment showing constant frequencies of bacterial and AMR contamination throughout the year. Whole genome sequencing (WGS), 16S rRNA oligotypes, and AMR identification allowed a high-resolution characterization of the hospital microbiome profile.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology
  • Bacteria / drug effects
  • Bacteria / genetics*
  • Bacteria / isolation & purification
  • Bacterial Load
  • Brazil
  • Cross Infection / microbiology
  • Cross Infection / pathology
  • Cross-Sectional Studies
  • Drug Resistance, Bacterial / drug effects
  • Drug Resistance, Bacterial / genetics*
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / isolation & purification
  • Humans
  • Infant, Newborn
  • Intensive Care Units
  • Intensive Care Units, Neonatal
  • RNA, Ribosomal, 16S / chemistry
  • RNA, Ribosomal, 16S / genetics
  • RNA, Ribosomal, 16S / metabolism
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / isolation & purification
  • Tertiary Care Centers
  • Whole Genome Sequencing

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • RNA, Ribosomal, 16S

Grants and funding

The funders BiomeHub and Albert Einstein Israelite Hospital (HIAE) provided support in form of salaries for the authors and were responsible for the project experimental design approval. HIAE have an additional role in defining sample collection points, but the analysis, the decision to publish and the manuscript preparation was independently performed by the researchers. The specific role of each author are included in the ‘author contributions’ section.